Table 7 Delay of treatment from diagnosis across HPV status.

From: Individual and community-level social determinant impact on HPV-differentiated nasopharyngeal carcinoma disparities in the USA

Delay of treatment

Characteristic

HPV positive

HPV negative

OR

95% CI

p-value

OR

95% CI

p-value

3 months

Younger Age (< 65 years)

1.13

0.42, 3.58

0.817

0.76

0.45, 1.34

0.336

Sex—Male

0.71

0.30, 1.82

0.458

1.10

0.63, 2.00

0.734

Race—Black

1.27

0.28, 4.38

0.727

1.02

0.42, 2.25

0.970

Race—Hispanic

0.72

0.04, 4.01

0.746

1.22

0.49, 2.76

0.654

Race—Asian

1.21

0.44, 3.18

0.702

0.95

0.53, 1.72

0.864

Yost Index—Lower Socioeconomic Status

0.69

0.28, 1.64

0.406

1.97

1.16, 3.42

0.012

Rurality

1.10

0.06, 6.30

0.929

0.36

0.02, 1.79

0.250

1 month

Younger Age (< 65 years)

0.47

0.27, 0.84

0.012

0.71

0.50, 1.01

0.055

Sex—Male

1.56

0.87, 2.92

0.134

0.98

0.69, 1.40

0.913

Race—Black

1.50

0.68, 3.16

0.305

1.50

0.87, 2.56

0.147

Race—Hispanic

0.80

0.22, 2.35

0.705

1.98

1.12, 3.47

0.019

Race—Asian

1.04

0.56, 1.91

0.902

1.29

0.89, 1.88

0.186

Yost Index—Lower Socioeconomic Status

0.94

0.56, 1.58

0.823

1.61

1.15, 2.25

0.005

Rurality

0.65

0.14, 2.18

0.511

2.09

0.87, 4.96

0.097

Back to article page